Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test

This publication has 17 references indexed in Scilit:

• MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity
  Neuropharmacology, 2004
• Altered Transcript Expression of NMDA Receptor-Associated Postsynaptic Proteins in the Thalamus of Subjects With Schizophrenia
  American Journal of Psychiatry, 2003
• Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans
  Psychopharmacology, 2003
• Anxiolytic-Like and Antidepressant-Like Activities of MCL0129 (1-[(S)-2-(4-Fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a Novel and Potent Nonpeptide Antagonist of the Melanocortin-4 Receptor
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• (2S,1‘S,2‘S,3‘R)-2-(2‘-Carboxy-3‘-methylcyclopropyl) Glycine Is a Potent and Selective Metabotropic Group 2 Receptor Agonist with Anxiolytic Properties
  Journal of Medicinal Chemistry, 2002
• Striatal Excitatory Amino Acid Transporter Transcript Expression in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
  Published by Springer Nature ,2002
• On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2001
• Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
  Journal of Neurochemistry, 2000
• PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
  Annual Review of Pharmacology and Toxicology, 1997
• Metabotropic Glutamate Receptors: Novel Targets for Drug Development
  Journal of Medicinal Chemistry, 1995